-       Report 
   - December 2024
    -  263 Pages 
    Global
   
   From       €4449EUR$4,950USD£3,902GBP 
                  -       Drug Pipelines 
   - May 2025
    -  150 Pages 
    Global
   
   From       €2373EUR$2,640USD£2,081GBP 
      €2966EUR$3,300USD£2,601GBP 
                  -       Report 
   - October 2025
    -  130 Pages 
    Global
   
   From       €2373EUR$2,640USD£2,081GBP 
      €2966EUR$3,300USD£2,601GBP 
                  -       Report 
   - September 2025
    -  220 Pages 
    Global
   
   From       €2157EUR$2,400USD£1,892GBP 
      €2696EUR$3,000USD£2,365GBP 
                  -       Report 
   - March 2025
    -  130 Pages 
    Global
   
   From       €2373EUR$2,640USD£2,081GBP 
      €2966EUR$3,300USD£2,601GBP 
                 -       Report 
   - July 2025
    -  765 Pages 
    Global
   
   From       €4449EUR$4,950USD£3,902GBP 
                -       Report 
   - August 2025
    -  165 Pages 
    Global
   
   From       €2022EUR$2,250USD£1,774GBP 
                  -       Report 
   - October 2024
    -  195 Pages 
    
   From       €3186EUR$3,545USD£2,794GBP 
      €3540EUR$3,939USD£3,105GBP 
                  -       Report 
   - October 2024
    -  196 Pages 
    
   From       €3186EUR$3,545USD£2,794GBP 
      €3540EUR$3,939USD£3,105GBP 
                  -       Report 
   - October 2024
    -  182 Pages 
    
   From       €3186EUR$3,545USD£2,794GBP 
      €3540EUR$3,939USD£3,105GBP 
                  -       Report 
   - October 2024
    -  195 Pages 
    
   From       €3186EUR$3,545USD£2,794GBP 
      €3540EUR$3,939USD£3,105GBP 
                -       Report 
   - April 2025
    -  388 Pages 
    Global
   
   From       €4179EUR$4,650USD£3,665GBP 
                -       Report 
   - May 2025
    -  170 Pages 
    Global
   
   From       €4179EUR$4,650USD£3,665GBP 
                  -       Report 
   - April 2025
    -  387 Pages 
    Global
   
   From       €3438EUR$3,825USD£3,015GBP 
      €4045EUR$4,500USD£3,547GBP 
                  -       Report 
   - February 2025
    -  227 Pages 
    Global
   
   From       €2912EUR$3,240USD£2,554GBP 
      €3640EUR$4,050USD£3,192GBP 
                -       Report 
   - September 2025
    -  131 Pages 
    Global
   
   From       €4179EUR$4,650USD£3,665GBP 
                -       Report 
   - May 2025
    -  116 Pages 
    Global
   
   From       €4179EUR$4,650USD£3,665GBP 
                -       Report 
   - May 2025
    -  124 Pages 
    Global
   
   From       €4179EUR$4,650USD£3,665GBP 
                -       Report 
   - April 2025
    -  162 Pages 
    Global
   
   From       €4179EUR$4,650USD£3,665GBP 
                -       Report 
   - March 2025
    -  219 Pages 
    Global
   
   From       €4179EUR$4,650USD£3,665GBP 
             
          The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically    more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less   Read more